ABVC BioPharma, Inc. (ABVC)

ABVC BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 2, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14	9	20	96	105	84
Market Cap Growth	93.67%	-55.74%	-78.95%	-8.30%	24.82%	-80.39%
Enterprise Value	19	12	22	95	109	87
Last Close Price	1.32	1.16	6.25	33.90	51.00	43.70
PS Ratio	26.00	58.72	20.85	269.96	216.85	119.59
PB Ratio	1.89	1.10	6.25	10.83	39.35	-672.31
P/TBV Ratio	0.98	1.07	6.53	10.86	30.46	-
EV/Sales Ratio	36.68	80.24	22.60	266.23	225.32	124.60
Debt / Equity Ratio	0.34	0.30	1.06	0.38	2.54	-39.56
Asset Turnover	0.03	0.01	0.08	0.03	0.05	0.11
Inventory Turnover	-	-	-	0.39	-	30.56
Quick Ratio	0.05	0.03	0.18	1.72	0.97	0.08
Current Ratio	0.34	0.28	0.54	2.07	1.27	0.13
Return on Equity (ROE)	-102.31%	-191.96%	-269.48%	-208.73%	-835.04%	-
Return on Assets (ROA)	-25.30%	-42.67%	-81.16%	-57.83%	-57.36%	-33.60%
Return on Capital (ROIC)	-33.19%	-59.60%	-100.17%	-67.64%	-74.68%	-220.20%
Earnings Yield	-51.00%	-117.48%	-81.21%	-13.37%	-9.35%	-4.34%
FCF Yield	-11.11%	-47.56%	-37.18%	-7.93%	-4.36%	-3.74%
Buyback Yield / Dilution	-187.47%	-36.92%	-26.39%	-27.07%	-12.67%	-47.26%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q